Sfoglia per RIVISTA
TARGETED ONCOLOGY
Collezione ASL Biella
Items : 2
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.
2024
ASL Biella
AOU Città della Salute di Torino
Casadei-Gardini A; Rimassa L; Antonuzzo L; Vivaldi C; Stefano C; Foti S; Rizzato MD; De Braud F; Aldrighetti L; Ratti F; Zanuso V; De Rosa A; Niger M; Rossari F; Fornaro L; Satolli MA; Brandi G; Garattini SK; Brunetti O; Pirrone C; Leone F; Diana A; Pretta A; Toma I; Landriscina M; Lorenzo A; Gusmaroli E; Bergamo F; Balsano R; et alii...
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). in Targeted oncology / Target Oncol. 2018 Aug;13(4):469-479. doi: 10.1007/s11523-018-0574-1.
2018
ASL Biella
Cioffi R; Pigozzi E; Giardina D; Loizzi V; Franzese E; Zavallone L; Ventriglia J; Bologna A; Orditura M; Cormio G; Longo L; Casanova C; Greco F; Gallà V; Scarpi E; Petrone M; Farolfi A; Pignata S; Giorda G; De Giorgi U;